img

Global and United States Hog Cholera Vaccine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Hog Cholera Vaccine Market Report & Forecast 2024-2034

Hog cholera, is a contagious viral disease of domestic and wild swine. 
Market Analysis and InsightsGlobal and United States Hog Cholera Vaccine Market
This report focuses on global and United States Hog Cholera Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Hog Cholera Vaccine revenue was US$ 150 million in 2024 and is forecast to a readjusted size of US$ 203.9 million by 2034 with a CAGR of 4.3% during the forecast period (2024-2034).
In United States the Hog Cholera Vaccine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Hog Cholera Vaccine include WINSUN, Boehringer Ingelheim, CAHIC, Chopper Biology, MSD Animal Health (Merck), ChengDu Tecbond, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc. The global five biggest players hold a share of % in 2024.
Global Hog Cholera Vaccine Scope and Market Size
Hog Cholera Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Hog Cholera Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Hog Cholera Vaccine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


WINSUN
Boehringer Ingelheim
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Segment by Type
Tissue Culture Origin
Cell Line Origin

Segment by Application


Government Tender
Market Sales
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Hog Cholera Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Hog Cholera Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Hog Cholera Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hog Cholera Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Hog Cholera Vaccine Product Introduction
1.2 Global Hog Cholera Vaccine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Hog Cholera Vaccine Sales in US$ Million for the Year 2018-2034
1.2.2 Global Hog Cholera Vaccine Sales in Volume for the Year 2018-2034
1.3 United States Hog Cholera Vaccine Outlook 2018 VS 2024 VS 2034
1.3.1 United States Hog Cholera Vaccine Sales in US$ Million for the Year 2018-2034
1.3.2 United States Hog Cholera Vaccine Sales in Volume for the Year 2018-2034
1.4 Hog Cholera Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Hog Cholera Vaccine in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Hog Cholera Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Hog Cholera Vaccine Market Dynamics
1.5.1 Hog Cholera Vaccine Industry Trends
1.5.2 Hog Cholera Vaccine Market Drivers
1.5.3 Hog Cholera Vaccine Market Challenges
1.5.4 Hog Cholera Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Hog Cholera Vaccine by Type
2.1 Hog Cholera Vaccine Market Segment by Type
2.1.1 Tissue Culture Origin
2.1.2 Cell Line Origin
2.2 Global Hog Cholera Vaccine Market Size by Type
2.2.1 Global Hog Cholera Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Hog Cholera Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Hog Cholera Vaccine Market Size by Type
2.3.1 United States Hog Cholera Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Hog Cholera Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Hog Cholera Vaccine by Application
3.1 Hog Cholera Vaccine Market Segment by Application
3.1.1 Government Tender
3.1.2 Market Sales
3.2 Global Hog Cholera Vaccine Market Size by Application
3.2.1 Global Hog Cholera Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Hog Cholera Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Hog Cholera Vaccine Market Size by Application
3.3.1 United States Hog Cholera Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Hog Cholera Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Hog Cholera Vaccine Competitor Landscape by Company
4.1 Global Hog Cholera Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Hog Cholera Vaccine, Ranked by Revenue (2024)
4.1.2 Global Hog Cholera Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Hog Cholera Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Hog Cholera Vaccine Price by Manufacturer (2018-2023)
4.2 Global Hog Cholera Vaccine Concentration Ratio (CR)
4.2.1 Hog Cholera Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hog Cholera Vaccine in 2024
4.2.3 Global Hog Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hog Cholera Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Hog Cholera Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Hog Cholera Vaccine Market Size by Company
4.7.1 Key Players of Hog Cholera Vaccine in United States, Ranked by Revenue (2024)
4.7.2 United States Hog Cholera Vaccine Revenue by Players (2018-2023)
4.7.3 United States Hog Cholera Vaccine Sales by Players (2018-2023)
5 Global Hog Cholera Vaccine Market Size by Region
5.1 Global Hog Cholera Vaccine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Hog Cholera Vaccine Market Size in Volume by Region (2018-2034)
5.2.1 Global Hog Cholera Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Hog Cholera Vaccine Sales in Volume Forecast by Region (2024-2034)
5.3 Global Hog Cholera Vaccine Market Size in Value by Region (2018-2034)
5.3.1 Global Hog Cholera Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Hog Cholera Vaccine Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Hog Cholera Vaccine Market Size YoY Growth 2018-2034
6.2 Americas Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Hog Cholera Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Hog Cholera Vaccine Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Hog Cholera Vaccine Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hog Cholera Vaccine Market Size YoY Growth 2018-2034
7.2 EMEA Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Hog Cholera Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Hog Cholera Vaccine Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Hog Cholera Vaccine Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hog Cholera Vaccine Market Size YoY Growth 2018-2034
8.2 China Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Hog Cholera Vaccine Market Size YoY Growth 2018-2034
9.2 APAC Hog Cholera Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Hog Cholera Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Hog Cholera Vaccine Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Hog Cholera Vaccine Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Hog Cholera Vaccine Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 WINSUN
10.1.1 WINSUN Company Information
10.1.2 WINSUN Description and Business Overview
10.1.3 WINSUN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 WINSUN Hog Cholera Vaccine Products Offered
10.1.5 WINSUN Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Description and Business Overview
10.2.3 Boehringer Ingelheim Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Hog Cholera Vaccine Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 CAHIC
10.3.1 CAHIC Company Information
10.3.2 CAHIC Description and Business Overview
10.3.3 CAHIC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CAHIC Hog Cholera Vaccine Products Offered
10.3.5 CAHIC Recent Development
10.4 Chopper Biology
10.4.1 Chopper Biology Company Information
10.4.2 Chopper Biology Description and Business Overview
10.4.3 Chopper Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chopper Biology Hog Cholera Vaccine Products Offered
10.4.5 Chopper Biology Recent Development
10.5 MSD Animal Health (Merck)
10.5.1 MSD Animal Health (Merck) Company Information
10.5.2 MSD Animal Health (Merck) Description and Business Overview
10.5.3 MSD Animal Health (Merck) Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 MSD Animal Health (Merck) Hog Cholera Vaccine Products Offered
10.5.5 MSD Animal Health (Merck) Recent Development
10.6 ChengDu Tecbond
10.6.1 ChengDu Tecbond Company Information
10.6.2 ChengDu Tecbond Description and Business Overview
10.6.3 ChengDu Tecbond Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ChengDu Tecbond Hog Cholera Vaccine Products Offered
10.6.5 ChengDu Tecbond Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Description and Business Overview
10.7.3 Ceva Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Hog Cholera Vaccine Products Offered
10.7.5 Ceva Recent Development
10.8 Harbin Veterinary Research Institute
10.8.1 Harbin Veterinary Research Institute Company Information
10.8.2 Harbin Veterinary Research Institute Description and Business Overview
10.8.3 Harbin Veterinary Research Institute Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Harbin Veterinary Research Institute Hog Cholera Vaccine Products Offered
10.8.5 Harbin Veterinary Research Institute Recent Development
10.9 Qilu Animal Health Products Factory
10.9.1 Qilu Animal Health Products Factory Company Information
10.9.2 Qilu Animal Health Products Factory Description and Business Overview
10.9.3 Qilu Animal Health Products Factory Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Qilu Animal Health Products Factory Hog Cholera Vaccine Products Offered
10.9.5 Qilu Animal Health Products Factory Recent Development
10.10 Ringpu Biology
10.10.1 Ringpu Biology Company Information
10.10.2 Ringpu Biology Description and Business Overview
10.10.3 Ringpu Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ringpu Biology Hog Cholera Vaccine Products Offered
10.10.5 Ringpu Biology Recent Development
10.11 DHN
10.11.1 DHN Company Information
10.11.2 DHN Description and Business Overview
10.11.3 DHN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 DHN Hog Cholera Vaccine Products Offered
10.11.5 DHN Recent Development
10.12 CAVAC
10.12.1 CAVAC Company Information
10.12.2 CAVAC Description and Business Overview
10.12.3 CAVAC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CAVAC Hog Cholera Vaccine Products Offered
10.12.5 CAVAC Recent Development
10.13 Komipharm
10.13.1 Komipharm Company Information
10.13.2 Komipharm Description and Business Overview
10.13.3 Komipharm Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Komipharm Hog Cholera Vaccine Products Offered
10.13.5 Komipharm Recent Development
10.14 Agrovet
10.14.1 Agrovet Company Information
10.14.2 Agrovet Description and Business Overview
10.14.3 Agrovet Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Agrovet Hog Cholera Vaccine Products Offered
10.14.5 Agrovet Recent Development
10.15 Bioveta
10.15.1 Bioveta Company Information
10.15.2 Bioveta Description and Business Overview
10.15.3 Bioveta Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bioveta Hog Cholera Vaccine Products Offered
10.15.5 Bioveta Recent Development
10.16 Jinyu Bio-Technology
10.16.1 Jinyu Bio-Technology Company Information
10.16.2 Jinyu Bio-Technology Description and Business Overview
10.16.3 Jinyu Bio-Technology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Jinyu Bio-Technology Hog Cholera Vaccine Products Offered
10.16.5 Jinyu Bio-Technology Recent Development
10.17 Institutul Pasteur
10.17.1 Institutul Pasteur Company Information
10.17.2 Institutul Pasteur Description and Business Overview
10.17.3 Institutul Pasteur Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Institutul Pasteur Hog Cholera Vaccine Products Offered
10.17.5 Institutul Pasteur Recent Development
10.18 MVP
10.18.1 MVP Company Information
10.18.2 MVP Description and Business Overview
10.18.3 MVP Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.18.4 MVP Hog Cholera Vaccine Products Offered
10.18.5 MVP Recent Development
10.19 Tecon
10.19.1 Tecon Company Information
10.19.2 Tecon Description and Business Overview
10.19.3 Tecon Hog Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Tecon Hog Cholera Vaccine Products Offered
10.19.5 Tecon Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hog Cholera Vaccine Industry Chain Analysis
11.2 Hog Cholera Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hog Cholera Vaccine Production Mode & Process
11.4 Hog Cholera Vaccine Sales and Marketing
11.4.1 Hog Cholera Vaccine Sales Channels
11.4.2 Hog Cholera Vaccine Distributors
11.5 Hog Cholera Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Hog Cholera Vaccine CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Hog Cholera Vaccine Market Trends
Table 3. Hog Cholera Vaccine Market Drivers
Table 4. Hog Cholera Vaccine Market Challenges
Table 5. Hog Cholera Vaccine Market Restraints
Table 6. Global Hog Cholera Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Hog Cholera Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Hog Cholera Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Hog Cholera Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Hog Cholera Vaccine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Hog Cholera Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Hog Cholera Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Hog Cholera Vaccine Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Hog Cholera Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Hog Cholera Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Hog Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hog Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hog Cholera Vaccine as of 2024)
Table 18. Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Hog Cholera Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Hog Cholera Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Hog Cholera Vaccine in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Hog Cholera Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Hog Cholera Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Hog Cholera Vaccine Sales by Players, (K Units), (2018-2023)
Table 26. United States Hog Cholera Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Hog Cholera Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Hog Cholera Vaccine Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Hog Cholera Vaccine Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Hog Cholera Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Hog Cholera Vaccine Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Hog Cholera Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Hog Cholera Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Hog Cholera Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Hog Cholera Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Hog Cholera Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Hog Cholera Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Hog Cholera Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Hog Cholera Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Hog Cholera Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Hog Cholera Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Hog Cholera Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Hog Cholera Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Hog Cholera Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Hog Cholera Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Hog Cholera Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 47. WINSUN Company Information
Table 48. WINSUN Description and Business Overview
Table 49. WINSUN Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. WINSUN Hog Cholera Vaccine Product
Table 51. WINSUN Recent Development
Table 52. Boehringer Ingelheim Company Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Boehringer Ingelheim Hog Cholera Vaccine Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. CAHIC Company Information
Table 58. CAHIC Description and Business Overview
Table 59. CAHIC Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. CAHIC Hog Cholera Vaccine Product
Table 61. CAHIC Recent Development
Table 62. Chopper Biology Company Information
Table 63. Chopper Biology Description and Business Overview
Table 64. Chopper Biology Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Chopper Biology Hog Cholera Vaccine Product
Table 66. Chopper Biology Recent Development
Table 67. MSD Animal Health (Merck) Company Information
Table 68. MSD Animal Health (Merck) Description and Business Overview
Table 69. MSD Animal Health (Merck) Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. MSD Animal Health (Merck) Hog Cholera Vaccine Product
Table 71. MSD Animal Health (Merck) Recent Development
Table 72. ChengDu Tecbond Company Information
Table 73. ChengDu Tecbond Description and Business Overview
Table 74. ChengDu Tecbond Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. ChengDu Tecbond Hog Cholera Vaccine Product
Table 76. ChengDu Tecbond Recent Development
Table 77. Ceva Company Information
Table 78. Ceva Description and Business Overview
Table 79. Ceva Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Ceva Hog Cholera Vaccine Product
Table 81. Ceva Recent Development
Table 82. Harbin Veterinary Research Institute Company Information
Table 83. Harbin Veterinary Research Institute Description and Business Overview
Table 84. Harbin Veterinary Research Institute Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Harbin Veterinary Research Institute Hog Cholera Vaccine Product
Table 86. Harbin Veterinary Research Institute Recent Development
Table 87. Qilu Animal Health Products Factory Company Information
Table 88. Qilu Animal Health Products Factory Description and Business Overview
Table 89. Qilu Animal Health Products Factory Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Qilu Animal Health Products Factory Hog Cholera Vaccine Product
Table 91. Qilu Animal Health Products Factory Recent Development
Table 92. Ringpu Biology Company Information
Table 93. Ringpu Biology Description and Business Overview
Table 94. Ringpu Biology Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Ringpu Biology Hog Cholera Vaccine Product
Table 96. Ringpu Biology Recent Development
Table 97. DHN Company Information
Table 98. DHN Description and Business Overview
Table 99. DHN Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. DHN Hog Cholera Vaccine Product
Table 101. DHN Recent Development
Table 102. CAVAC Company Information
Table 103. CAVAC Description and Business Overview
Table 104. CAVAC Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. CAVAC Hog Cholera Vaccine Product
Table 106. CAVAC Recent Development
Table 107. Komipharm Company Information
Table 108. Komipharm Description and Business Overview
Table 109. Komipharm Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Komipharm Hog Cholera Vaccine Product
Table 111. Komipharm Recent Development
Table 112. Agrovet Company Information
Table 113. Agrovet Description and Business Overview
Table 114. Agrovet Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Agrovet Hog Cholera Vaccine Product
Table 116. Agrovet Recent Development
Table 117. Bioveta Company Information
Table 118. Bioveta Description and Business Overview
Table 119. Bioveta Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Bioveta Hog Cholera Vaccine Product
Table 121. Bioveta Recent Development
Table 122. Jinyu Bio-Technology Company Information
Table 123. Jinyu Bio-Technology Description and Business Overview
Table 124. Jinyu Bio-Technology Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Jinyu Bio-Technology Hog Cholera Vaccine Product
Table 126. Jinyu Bio-Technology Recent Development
Table 127. Institutul Pasteur Company Information
Table 128. Institutul Pasteur Description and Business Overview
Table 129. Institutul Pasteur Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Institutul Pasteur Hog Cholera Vaccine Product
Table 131. Institutul Pasteur Recent Development
Table 132. MVP Company Information
Table 133. MVP Description and Business Overview
Table 134. MVP Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. MVP Hog Cholera Vaccine Product
Table 136. MVP Recent Development
Table 137. Tecon Company Information
Table 138. Tecon Description and Business Overview
Table 139. Tecon Hog Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Tecon Hog Cholera Vaccine Product
Table 141. Tecon Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Hog Cholera Vaccine Customers List
Table 145. Hog Cholera Vaccine Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Hog Cholera Vaccine Product Picture
Figure 2. Global Hog Cholera Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Hog Cholera Vaccine Market Size 2018-2034 (US$ Million)
Figure 4. Global Hog Cholera Vaccine Sales 2018-2034 (K Units)
Figure 5. United States Hog Cholera Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Hog Cholera Vaccine Market Size 2018-2034 (US$ Million)
Figure 7. United States Hog Cholera Vaccine Sales 2018-2034 (K Units)
Figure 8. United States Hog Cholera Vaccine Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Hog Cholera Vaccine Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Hog Cholera Vaccine Report Years Considered
Figure 11. Product Picture of Tissue Culture Origin
Figure 12. Product Picture of Cell Line Origin
Figure 13. Global Hog Cholera Vaccine Market Share by Type in 2024 & 2034
Figure 14. Global Hog Cholera Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Hog Cholera Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 17. Global Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Hog Cholera Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 19. United States Hog Cholera Vaccine Market Share by Type in 2024 & 2034
Figure 20. United States Hog Cholera Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. United States Hog Cholera Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 22. United States Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 23. United States Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 24. United States Hog Cholera Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Government Tender
Figure 26. Product Picture of Market Sales
Figure 27. Global Hog Cholera Vaccine Market Share by Application in 2024 & 2034
Figure 28. Global Hog Cholera Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 29. Global Hog Cholera Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 30. Global Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 31. Global Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 32. Global Hog Cholera Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 33. United States Hog Cholera Vaccine Market Share by Application in 2024 & 2034
Figure 34. United States Hog Cholera Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 35. United States Hog Cholera Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 36. United States Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 37. United States Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 38. United States Hog Cholera Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 39. Americas Hog Cholera Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 40. Americas Hog Cholera Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 41. Americas Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 42. Americas Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 43. Americas Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 44. Americas Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 45. United States Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 46. Canada Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Mexico Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. EMEA Hog Cholera Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 50. EMEA Hog Cholera Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 51. EMEA Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 52. EMEA Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 53. EMEA Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 54. EMEA Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 55. Europe Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 56. Middle East Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Africa Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. China Hog Cholera Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 59. China Hog Cholera Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 60. China Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 61. China Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 62. China Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 63. China Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 64. APAC Hog Cholera Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 65. APAC Hog Cholera Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 66. APAC Hog Cholera Vaccine Sales by Type (2018-2034) & (K Units)
Figure 67. APAC Hog Cholera Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 68. APAC Hog Cholera Vaccine Sales by Application (2018-2034) & (K Units)
Figure 69. APAC Hog Cholera Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 70. Japan Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 71. South Korea Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. China Taiwan Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. Southeast Asia Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. India Hog Cholera Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Hog Cholera Vaccine Value Chain
Figure 76. Hog Cholera Vaccine Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed